$12 million investment to create 100 new jobs
COLUMBIA, S.C. – KB Biotech Solutions, a venture of Chinese-based Anhui Chem-bright Bioengineering Co. Ltd., is launching new manufacturing operations in Dillon County. The $12 million investment is expected to create 100 new jobs.
Founded in August 2006, Anhui Chem-bright Bioengineering Co. operates the largest production base of natural steroidal raw materials and intermediates in China. With an agricultural industrialization-leading enterprise, the company specializes in biomedicine and the deep processing of agricultural byproducts. Its products are widely used in pharmaceutical raw materials, cosmetics, functional foods and feed additives.
Located at 1317 East Main Street in Dillon, S.C., KB Biotech Solutions has purchased the 55,000-square-foot Polar Cold Storage building. Hiring for the new positions should begin in the first quarter of 2018.
The Coordinating Council for Economic Development has approved job development credits related to this project. A $150,000 Rural Infrastructure Fund grant was also awarded to Dillon County to assist with the costs of building upfit.
“This announcement is great news for our company, and we are excited to be locating in Dillon County. Between its proximity to suppliers, easy transportation opportunities and a dependable labor force, we look forward to what the future has in store here.” –KB Biotech Solutions CEO Yan Zhao
“South Carolina’s manufacturing industry continues to take our state to heights never reached before, and this announcement is further proof of that. The 100 new jobs that KB Biotech Solutions is creating in Dillon County shows that this great company is committed to our state and our people, and we couldn’t be more grateful for this new partnership.” –Gov. Henry McMaster
“Congratulations to KB Biotech Solutions for announcing its new Dillon County operations. As a state that prides itself on its booming manufacturing sector, we celebrate this new announcement and can’t wait to see the difference these new jobs will make in the local community.” –Secretary of Commerce Bobby Hitt
“Today’s announcement is proof that good things come to those who wait. We decided to make the commitment upfront of providing infrastructure, a talented workforce and available buildings, and it has paid off for Dillon County. The seeds were planted early on and now our economic development garden has begun to bear fruit. We are happy to announce that we are adding more jobs to our community and providing more opportunities for our citizens.” –Dillon County Council Chairman Archie Scott
“It is great to see the partnership between NESA, Dillon County and the S.C. Department of Commerce yielding such positive results for the region. We wish KB Biotech Solutions much success as they establish operations in Dillon County.” –NESA Executive Committee Chairman Sen. Luke Rankin, Esq.
“South Carolina Ports Authority looks forward to serving the export needs of KB Biotech Solutions through both Inland Port Dillon, which will open early next year, as well as our Charleston facilities. The Port plays an important role in the international supply chains of manufacturers across our state, and we look forward to supporting their addition to our state’s growing economy.” –S.C. Ports Authority President and CEO Jim Newsome
“We take tremendous pride in the agribusiness industry in South Carolina, and we’re constantly looking for new growth and opportunity. KB Biotech Solutions is another great success story for our state as we continue to strengthen our presence in the American and global agricultural markets.” –S.C. Agriculture Commissioner Hugh Weathers
FIVE FAST FACTS
- KB Biotech Solutions is launching new Dillon County operations.
- $12 million investment to create 100 new jobs.
- A venture of Anhui Chem-bright Bioengineering Co. Ltd., KB Biotech Solutions specializes in biomedicine and deep processing of agricultural byproducts.
- The new operations will be located at 1317 East Main Street in Dillon, S.C.
- Hiring for the new positions should begin in the first quarter of 2018.